Biatorbagy, Hungary

Katalin Marmarosi Nee Kellner


Average Co-Inventor Count = 7.9

ph-index = 7

Forward Citations = 311(Granted Patents)


Company Filing History:


Years Active: 1984-1995

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Katalin Marmarosi Nee Kellner: A Trailblazer in Pharmaceutical Innovations

Introduction: Katalin Marmarosi Nee Kellner, an accomplished inventor based in Biatorbagy, Hungary, has made significant contributions to the field of pharmaceuticals, particularly in the area of transdermal drug delivery systems. With a remarkable portfolio of 14 patents, her innovative approaches have paved the way for advancements in medical treatments.

Latest Patents: Among her latest inventions, Katalin has developed an anhydrous transdermal composition that encompasses a 20 to 100% lyotropic liquid crystalline arrangement. This innovative formulation promises to enhance the effectiveness of drug delivery through the skin. Additionally, she has created a plant protective microemulsion composition containing pyrethroids, showcasing her dedication to both human health and environmental safety.

Career Highlights: Katalin's professional journey includes pivotal roles at leading pharmaceutical companies, namely Chinoin Gyógyszer és Vegyészeti Termékek Gyár Rt. and Borsodi Vegyi Kombinát. Her expertise and contributions in these organizations have not only fostered innovation but have also solidified her reputation as a leading figure in the pharmaceutical industry.

Collaborations: Throughout her career, Katalin has collaborated with esteemed colleagues such as Andras Szego and Sandor Virag. These partnerships have been instrumental in driving forward research and enhancing the quality of their innovative endeavors.

Conclusion: Katalin Marmarosi Nee Kellner stands as a notable inventor whose work in pharmaceuticals has led to significant advancements in drug delivery systems. Her extensive patent portfolio and collaborations with other industry experts underscore her invaluable contributions to the field, marking her as a trailblazer in pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…